Studying children's growth in self-regulation using changing measures to account for heterotypic continuity: A Bayesian approach to developmental scaling

Self-regulation is thought to show heterotypic continuity-its individual differences endure but its behavioral manifestations change across development. Thus, different measures across time may be necessary to account for heterotypic continuity of self-regulation. This longitudinal study examined children's (N = 108) self-regulation development using 17 measures, including 15 performance-based measures, two questionnaires, and three raters across seven time points. It is the first to use different measures of self-regulation over time to account for heterotypic continuity while using developmental scaling to link the measures onto the same scale for more accurate growth estimates. Assessed facets included inhibitory control, delayed gratification, sustained attention, and executive functions. Some measures differed across ages to retain construct validity and account for heterotypic continuity. A Bayesian longitudinal mixed model for developmental scaling was developed to link the differing measures onto the same scale. This allowed charting children's self-regulation growth across ages 3-7 years and relating it to both predictors and outcomes. Rapid growth occurred from ages 3-6. As a validation of the developmental scaling approach, greater self-regulation was associated with better school readiness (math and reading skills) and fewer externalizing problems. Our multi-wave, multi-facet, multi-method, multi-measure, multi-rater, developmental scaling approach is the most comprehensive to date for assessing the development of self-regulation. This approach demonstrates that developmental scaling may enable studying development of self-regulation across the lifespan.

Studying a Moving Target in Development: The Challenge and Opportunity of Heterotypic Continuity

Many psychological constructs show heterotypic continuity-their behavioral manifestations change with development but their meaning remains the same (e.g., externalizing problems). However, research has paid little attention to how to account for heterotypic continuity. Conceptual and methodological challenges of heterotypic continuity may prevent researchers from examining lengthy developmental spans. Developmental theory requires that measurement accommodate changes in manifestation of constructs. Simulation and empirical work demonstrate that failure to account for heterotypic continuity when collecting or analyzing longitudinal data results in faulty developmental inferences. Accounting for heterotypic continuity may require using different measures across time with approaches that link measures on a comparable scale. Creating a developmental scale (i.e., developmental scaling) is recommended to link measures across time and account for heterotypic continuity, which is crucial in understanding development across the lifespan. The current synthesized review defines heterotypic continuity, describes how to identify it, and presents solutions to account for it. We note challenges of addressing heterotypic continuity, and propose steps in leveraging opportunities it creates to advance empirical study of development.

Recent advances in understanding nuclear size and shape

Size and shape are important aspects of nuclear structure. While normal cells maintain nuclear size within a defined range, altered nuclear size and shape are associated with a variety of diseases. It is unknown if altered nuclear morphology contributes to pathology, and answering this question requires a better understanding of the mechanisms that control nuclear size and shape. In this review, we discuss recent advances in our understanding of the mechanisms that regulate nuclear morphology, focusing on nucleocytoplasmic transport, nuclear lamins, the endoplasmic reticulum, the cell cycle, and potential links between nuclear size and size regulation of other organelles. We then discuss the functional significance of nuclear morphology in the context of early embryonic development. Looking toward the future, we review new experimental approaches that promise to provide new insights into mechanisms of nuclear size control, in particular microfluidic-based technologies, and discuss how altered nuclear morphology might impact chromatin organization and physiology of diseased cells.